TY - JOUR AU - Louis, D. N. AU - Perry, A. AU - Reifenberger, G. PY - 2016 DA - 2016// TI - The 2016 World Health Organization classification of tumors of the central nervous system: a summary JO - Acta Neuropathol VL - 131 UR - https://doi.org/10.1007/s00401-016-1545-1 DO - 10.1007/s00401-016-1545-1 ID - Louis2016 ER - TY - JOUR AU - Oraiopoulou, M. E. AU - Tzamali, E. AU - Tzedakis, G. PY - 2017 DA - 2017// TI - In vitro/in Silico study on the role of doubling time heterogeneity among primary glioblastoma cell lines JO - Biomed Res Int VL - 2017 UR - https://doi.org/10.1155/2017/8569328 DO - 10.1155/2017/8569328 ID - Oraiopoulou2017 ER - TY - JOUR AU - Ellingson, B. M. AU - Nguyen, H. N. AU - Lai, A. PY - 2016 DA - 2016// TI - Contrast-enhancing tumor growth dynamics of preoperative, treatment-naive human glioblastoma JO - Cancer VL - 122 UR - https://doi.org/10.1002/cncr.29957 DO - 10.1002/cncr.29957 ID - Ellingson2016 ER - TY - JOUR AU - Stupp, R. AU - Mason, W. P. AU - Bent, M. J. PY - 2005 DA - 2005// TI - European Organisation for Research and Treatment of Cancer Brain Tumor and Radiotherapy Groups; National Cancer Institute of Canada Clinical Trials Group. Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma JO - N Engl J Med VL - 352 UR - https://doi.org/10.1056/NEJMoa043330 DO - 10.1056/NEJMoa043330 ID - Stupp2005 ER - TY - JOUR AU - Gilbert, M. R. AU - Dignam, J. J. AU - Armstrong, T. S. PY - 2014 DA - 2014// TI - A randomized trial of bevacizumab for newly diagnosed glioblastoma JO - N Engl J Med VL - 370 UR - https://doi.org/10.1056/NEJMoa1308573 DO - 10.1056/NEJMoa1308573 ID - Gilbert2014 ER - TY - JOUR AU - Gilbert, M. R. AU - Wang, M. AU - Aldape, K. D. PY - 2013 DA - 2013// TI - Dose-dense temozolomide for newly diagnosed glioblastoma: a randomized phase III clinical trial JO - J ClinOncol VL - 31 UR - https://doi.org/10.1200/JCO.2013.49.6968 DO - 10.1200/JCO.2013.49.6968 ID - Gilbert2013 ER - TY - JOUR AU - Chinot, O. L. AU - Wick, W. AU - Mason, W. PY - 2014 DA - 2014// TI - Bevacizumab plus radiotherapy-temozolomide for newly diagnosed glioblastoma JO - N Engl J Med VL - 370 UR - https://doi.org/10.1056/NEJMoa1308345 DO - 10.1056/NEJMoa1308345 ID - Chinot2014 ER - TY - JOUR AU - Herrlinger, U. AU - Tzaridis, T. AU - Mack, F. PY - 2019 DA - 2019// TI - Lomustine-temozolomide combination therapy versus standard temozolomide therapy in patients with newly diagnosed glioblastoma with methylated MGMT promoter (CeTeG/NOA-09): a randomized, open-label, phase 3 trial JO - Lancet VL - 393 UR - https://doi.org/10.1016/S0140-6736(18)31791-4 DO - 10.1016/S0140-6736(18)31791-4 ID - Herrlinger2019 ER - TY - JOUR AU - Pedicini, P. AU - Fiorentino, A. AU - Simeon, V. PY - 2014 DA - 2014// TI - Clinical radiobiology of glioblastoma multiforme: estimation of tumor control probability from various radiotherapy fractionation schemes JO - StrahlentherOnkol VL - 190 UR - https://doi.org/10.1007/s00066-014-0638-9 DO - 10.1007/s00066-014-0638-9 ID - Pedicini2014 ER - TY - STD TI - NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines®) Central Nervous System Cancers Version 3.2019 — October 18, 2019. https://www.nccn.org/professionals/physician_gls/pdf/cns.pdf. Accessed 17 Nov 2019. UR - https://www.nccn.org/professionals/physician_gls/pdf/cns.pdf ID - ref10 ER - TY - JOUR AU - Stupp, R. AU - Taillibert, S. AU - Kanner, A. PY - 2017 DA - 2017// TI - Effect of tumor-treating fields plus maintenance temozolomide vs maintenance temozolomide alone on survival in patients with glioblastoma: a randomized clinical trial JO - JAMA VL - 318 UR - https://doi.org/10.1001/jama.2017.18718 DO - 10.1001/jama.2017.18718 ID - Stupp2017 ER - TY - JOUR AU - Stupp, R. AU - Wong, E. T. AU - Kanner, A. A. PY - 2012 DA - 2012// TI - Nove TTG-100A versus physician’s choice chemotherapy in recurrent gliobalstoma: a randomized phase III trial of a novel treatment modality JO - Eur J Cancer VL - 48 UR - https://doi.org/10.1016/j.ejca.2012.04.011 DO - 10.1016/j.ejca.2012.04.011 ID - Stupp2012 ER - TY - STD TI - Novocure. Optune – instructions for use. Document Number: QSD-QR-703. Revision 02. Issue Date: January 2019 Novocure. https://www.optune.com/Content/pdfs/Optune_IFU_8.5x11.pdf. Accessed 17 Nov 2019. UR - https://www.optune.com/Content/pdfs/Optune_IFU_8.5x11.pdf ID - ref13 ER - TY - JOUR AU - Kirson, E. D. PY - 2007 DA - 2007// TI - Alternating electric fields arrest cell proliferation in animal tumor models and human brain tumors JO - Proc Natl Acad Sci U S A VL - 104 UR - https://doi.org/10.1073/pnas.0702916104 DO - 10.1073/pnas.0702916104 ID - Kirson2007 ER - TY - JOUR AU - Giladi, M. AU - Schneiderman, R. S. AU - Voloshin, T. PY - 2015 DA - 2015// TI - Mitotic spindle disruption by alternating electric fields leads to improper chromosome segregation and mitotic catastrophe in cancer cells JO - Sci Rep VL - 5 UR - https://doi.org/10.1038/srep18046 DO - 10.1038/srep18046 ID - Giladi2015 ER - TY - JOUR AU - Giladi, M. AU - Munster, M. AU - Schneiderman, R. S. PY - 2017 DA - 2017// TI - Tumor treating fields (TTFields) delay DNA damage repair following radiation treatment of glioma cells JO - Radiatoncol VL - 12 ID - Giladi2017 ER - TY - JOUR AU - Kim, E. H. AU - Song, H. S. AU - Yoo, S. H. AU - Yoon, M. PY - 2016 DA - 2016// TI - Tumor treating fields inhibit glioblastoma cell migration, invasion and angiogenesis JO - Oncotarget VL - 7 UR - https://doi.org/10.18632/oncotarget.11372 DO - 10.18632/oncotarget.11372 ID - Kim2016 ER - TY - JOUR AU - Silginer, M. AU - Weller, M. AU - Stupp, R. AU - Roth, P. PY - 2017 DA - 2017// TI - Biological activity of tumor-treating fields in preclinical glioma models JO - Cell Death Dis VL - 8 UR - https://doi.org/10.1038/cddis.2017.171 DO - 10.1038/cddis.2017.171 ID - Silginer2017 ER - TY - STD TI - Grossman R, Limon D, Bokstein F, Blumenthal D, Harush CB, Ram Z. Tumor Treating Fields combined with radiotherapy and temozolomide for the treatment of newly diagnosed glioblastoma: Final results from a pilot study. Neuro-Oncology. 2019;(Issue Supplement_6):vi23–4. https://doi.org/10.1093/neuonc/noz175.088. ID - ref19 ER - TY - JOUR AU - Berkelmann, L. AU - Bader, A. AU - Meshksar, S. PY - 2019 DA - 2019// TI - Tumour-treating fields (TTFields): investigations on the mechanism of action by electromagnetic exposure of cells in telophase/cytokinesis JO - Sci Rep VL - 9 UR - https://doi.org/10.1038/s41598-019-43621-9 DO - 10.1038/s41598-019-43621-9 ID - Berkelmann2019 ER - TY - JOUR AU - Karanam, N. K. AU - Srinivasan, K. AU - Ding, L. PY - 2017 DA - 2017// TI - Tumor-treating fields elict a conditional vulnerability to ionizing radiation via the downregulation of BRCA1 signaling and reduced DNA double-strand break repair capacity in non-small cell lung cancer cell lines JO - Cell Death Dis VL - 8 UR - https://doi.org/10.1038/cddis.2017.136 DO - 10.1038/cddis.2017.136 ID - Karanam2017 ER - TY - JOUR AU - Niyazi, M. AU - Brada, M. AU - Chalmers, A. J. PY - 2016 DA - 2016// TI - ESTRO-ACROP guideline "target delineation of glioblastomas" JO - Radiother Oncol VL - 118 UR - https://doi.org/10.1016/j.radonc.2015.12.003 DO - 10.1016/j.radonc.2015.12.003 ID - Niyazi2016 ER - TY - STD TI - Hoffmann L, Alber M, Söhn M, Elstrøm UV. Validation of the Acuros XB dose calculation algorithm versus Monte Carlo for clinical treatment plans. Med Phys. 2018. https://doi.org/10.1002/mp.13053. ID - ref23 ER - TY - STD TI - Sikora M. Virtual Source Modelling of Photon Beams for Monte Carlo Based Radiation Therapy Treatment Planning, PhD thesis. http://bora.uib.no/bitstream/handle/1956/5135/Dr.thesis_Marcin%20Sikora.pdf?sequence=1&isAllowed=y. Accessed 27 Dec 2019. UR - http://bora.uib.no/bitstream/handle/1956/5135/Dr.thesis_Marcin%20Sikora.pdf?sequence=1&isAllowed=y ID - ref24 ER - TY - JOUR AU - Niemierko, A. PY - 1997 DA - 1997// TI - Reporting and analyzing dose distributions: a concept of equivalent uniform dose JO - Med Phys VL - 24 UR - https://doi.org/10.1118/1.598063 DO - 10.1118/1.598063 ID - Niemierko1997 ER - TY - JOUR AU - Stuschke, M. AU - Budach, V. AU - Stüben, G. PY - 1995 DA - 1995// TI - Heterogeneity in the fractionation sensitivities of human tumor cell lines: studies in a three-dimensional model system JO - Int J Radiat Oncol Biol Phys VL - 32 UR - https://doi.org/10.1016/0360-3016(95)00528-7 DO - 10.1016/0360-3016(95)00528-7 ID - Stuschke1995 ER - TY - JOUR AU - Suit, H. AU - Skates, S. AU - Taghian, A. PY - 1992 DA - 1992// TI - Clinical implications of heterogeneity of tumor response to radiation therapy JO - RadiotherOncol VL - 25 ID - Suit1992 ER - TY - STD TI - Emami B, Lyman J, Brown A, et al. Tolerance of normal tissue to therapeutic irradiation. Int J Radiat Oncol Biol Phys. 1991; 21(1):109–22. https://doi.org/10.1016/0360-3016(91)90171-y. ID - ref28 ER - TY - JOUR AU - Bender, E. AU - Kozak, K. AU - Howard, S. AU - Hayes, L. AU - Bayouth, J. AU - Robins, H. I. PY - 2017 DA - 2017// TI - The effect of Optune™ tumor treating fields transducer arrays on skin radiation dose during radiotherapy JO - J Clin Neurosci VL - 42 UR - https://doi.org/10.1016/j.jocn.2017.04.002 DO - 10.1016/j.jocn.2017.04.002 ID - Bender2017 ER - TY - JOUR AU - Li, T. AU - Shukla, G. AU - Peng, C. AU - Lockamy, V. AU - Liu, H. AU - Shi, W. PY - 2018 DA - 2018// TI - Dosimetric impact of tumor treating fields device for glioblastoma patients undergoing simultaneous radiation therapy JO - Front Oncol VL - 8 UR - https://doi.org/10.3389/fonc.2018.00051 DO - 10.3389/fonc.2018.00051 ID - Li2018 ER - TY - JOUR AU - Straube, C. M. AU - Kampfer, O. S. PY - 2018 DA - 2018// TI - Dosimetric impact of tumor treating field (TTField)transducer arrays onto treatment plans for glioblastomas - a planning study JO - Radiat Oncol VL - 13 UR - https://doi.org/10.1186/s13014-018-0976-3 DO - 10.1186/s13014-018-0976-3 ID - Straube2018 ER - TY - JOUR AU - Reis, C. Q. M. PY - 2019 DA - 2019// TI - Effects of heterogeneities in dose distributions under nonreference conditions: Monte Carlo simulation vs dose calculation algorithms JO - Med Dosim VL - 44 UR - https://doi.org/10.1016/j.meddos.2018.02.009 DO - 10.1016/j.meddos.2018.02.009 ID - Reis2019 ER - TY - JOUR AU - Alhakeem, E. Y. PY - 2015 DA - 2015// TI - Comparative evaluation of modern dosimetry techniques near low- and high-density heterogeneities JO - J ApplClin Med Phys VL - 16 ID - Alhakeem2015 ER - TY - JOUR AU - Ojala, J. AU - Kapanen, M. AU - Sipilä, P. PY - 2014 DA - 2014// TI - The accuracy of the Acuros XB algorithm for radiation beams traversing a metallic hip implant – comparison with measurements and Monte Carlo simulations JO - J ApplClin Med Phys VL - 15 ID - Ojala2014 ER - TY - JOUR AU - Onizuka, R. AU - Araki, F. AU - Ohno, T. PY - 2016 DA - 2016// TI - Accuracy of dose calculation algorithms for virtual heterogeneous phantoms and intensity-modulated radiation therapy in the head and neck JO - Radiol Phys tevhnol VL - 9 UR - https://doi.org/10.1007/s12194-015-0336-z DO - 10.1007/s12194-015-0336-z ID - Onizuka2016 ER -